Credit: Getty Images. Insulin glargine 300 Units/mL was found to be comparable to insulin glargine 100 Units/mL in providing effective glycemic control in pediatric patients with type 1 diabetes.
ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...
Sanofi presented non-inferiority results of the first ever head-to-head clinical study comparing its long-acting insulin Toujeo® (Gla-300) to insulin degludec. Results of the study, called BRIGHT, ...
After the first 16 patients were treated, the multidisciplinary team met to assess the safety and effectiveness of the insulin infusion protocol. Three changes to the protocol were recommended. The ...
--- First 200 units/ml rapid-acting insulin product for the treatment of diabetes INDIANAPOLIS, Oct. 3, 2014 /PRNewswire/ -- Eli Lilly and Company today announced that the European Commission has ...
The contributions of Russell White, M.D., Richard Blanchard, M.D., Robert Thacker, M.D., Steven Epstein, M.D., Karen Kent, R.N., M.S., and Ann Lafferty, R.D., are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback